Lewy body pathology accelerates AD progression

IF 28.2 1区医学 Q1 CLINICAL NEUROLOGY

Nature Reviews Neurology Pub Date : 2024-10-14 DOI:10.1038/s41582-024-01028-9

Heather Wood

引用次数: 0

查看原文本刊更多论文

路易体病理学加速了注意力缺失症的进展

最新研究发现，除了阿尔茨海默病（AD）病理变化外，路易体（LB）病理变化的存在还与阿尔茨海默病相关疾病的进展加速有关。在一项涉及795名轻度认知障碍或痴呆症患者的研究中，与AD+LB-、AD-LB+或AD-LB-患者相比，脑脊液中存在AD+LB+生物标志物的患者认知能力下降更快，皮质代谢更低。研究结果表明，检测LB病理学可能对AD患者具有预后价值。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Neurology 医学-临床神经学

CiteScore

29.90

自引率

0.80%

发文量

138

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Neurology aims to be the premier source of reviews and commentaries for the scientific and clinical communities we serve. We want to provide an unparalleled service to authors, referees, and readers, and we work hard to maximize the usefulness and impact of each article. The journal publishes Research Highlights, Comments, News & Views, Reviews, Consensus Statements, and Perspectives relevant to researchers and clinicians working in the field of neurology. Our broad scope ensures that the work we publish reaches the widest possible audience. Our articles are authoritative, accessible, and enhanced with clearly understandable figures, tables, and other display items. This page gives more detail about the aims and scope of the journal.